|
|
|
Volumn 274, Issue 7344, 2005, Pages 417-418
|
|
Pharmaceutical programme for public health - Priorities for the next decade
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMFEBUTAMONE;
ANTIOBESITY AGENT;
METHADONE;
NICOTINE DERIVATIVE;
ADOLESCENT PREGNANCY;
CANCER;
CANCER MORTALITY;
CLINICAL PHARMACY;
COMMUNITY CARE;
CONDOM;
COST EFFECTIVENESS ANALYSIS;
DRUG DEPENDENCE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
GOVERNMENT;
HEALTH CARE ACCESS;
HEALTH CARE DELIVERY;
HEALTH PROGRAM;
HEALTH PROMOTION;
HEART DISEASE;
HORMONAL CONTRACEPTION;
HOSPITAL PHARMACY;
HUMAN;
LIFESTYLE;
LONG TERM CARE;
MEDICAL PROFESSION;
MORTALITY;
NATIONAL HEALTH SERVICE;
NICOTINE REPLACEMENT THERAPY;
NOTE;
OBESITY;
PHARMACEUTICAL CARE;
PHARMACIST;
PRESCRIPTION;
PRIMARY MEDICAL CARE;
PUBLIC HEALTH SERVICE;
RISK FACTOR;
SECONDARY PREVENTION;
SMOKING;
SMOKING CESSATION;
STROKE;
TOBACCO DEPENDENCE;
UNITED KINGDOM;
|
|
EID: 17444408916
PISSN: 00316873
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|